Does the media favor ELAN or TEVA?

In the previous week, Teva Pharmaceutical Industries had 21 more articles in the media than Elanco Animal Health. MarketBeat recorded 26 mentions for Teva Pharmaceutical Industries and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat Teva Pharmaceutical Industries' score of 0.88 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teva Pharmaceutical Industries 8 Very Positive mention(s) 5 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ONC or ELAN?

In the previous week, BeOne Medicines had 5 more articles in the media than Elanco Animal Health. MarketBeat recorded 10 mentions for BeOne Medicines and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat BeOne Medicines' score of 1.22 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ELAN or RPRX?

In the previous week, Royalty Pharma had 7 more articles in the media than Elanco Animal Health. MarketBeat recorded 12 mentions for Royalty Pharma and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat Royalty Pharma's score of 0.66 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Royalty Pharma 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ELAN or ZTS?

In the previous week, Zoetis had 13 more articles in the media than Elanco Animal Health. MarketBeat recorded 18 mentions for Zoetis and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat Zoetis' score of 1.30 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zoetis 14 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer VTRS or ELAN?

In the previous week, Elanco Animal Health had 2 more articles in the media than Viatris. MarketBeat recorded 5 mentions for Elanco Animal Health and 3 mentions for Viatris. Elanco Animal Health's average media sentiment score of 1.30 beat Viatris' score of 0.33 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viatris 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Elanco Animal Health 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Elanco Animal Health (ELAN) Competitors

$23.18 -0.38 (-1.59%)

As of 12:19 PM Eastern

Compare

ELAN vs. TEVA, ONC, RPRX, ZTS, and VTRS

Should you buy Elanco Animal Health stock or one of its competitors? Elanco Animal Health's main competitors and comparable companies include Teva Pharmaceutical Industries (TEVA), BeOne Medicines (ONC), Royalty Pharma (RPRX), Zoetis (ZTS), and Viatris (VTRS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Elanco Animal Health (NYSE:ELAN) and Teva Pharmaceutical Industries (NYSE:TEVA) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

Elanco Animal Health has a beta of 1.68, suggesting that its share price is 68% more volatile than the broader market. Comparatively, Teva Pharmaceutical Industries has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Teva Pharmaceutical Industries has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Teva Pharmaceutical Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.46	-$232M	-$0.41	N/A
Teva Pharmaceutical Industries	$17.26B	2.45	$1.41B	$0.60	60.49

In the previous week, Teva Pharmaceutical Industries had 21 more articles in the media than Elanco Animal Health. MarketBeat recorded 26 mentions for Teva Pharmaceutical Industries and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat Teva Pharmaceutical Industries' score of 0.88 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teva Pharmaceutical Industries	8 Very Positive mention(s)	5 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Teva Pharmaceutical Industries has a net margin of 4.08% compared to Elanco Animal Health's net margin of -3.96%. Teva Pharmaceutical Industries' return on equity of 32.64% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-3.96%	8.13%	3.99%
Teva Pharmaceutical Industries	4.08%	32.64%	6.34%

97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. 1.1% of Elanco Animal Health shares are held by company insiders. Comparatively, 0.5% of Teva Pharmaceutical Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Elanco Animal Health currently has a consensus target price of $29.09, suggesting a potential upside of 25.53%. Teva Pharmaceutical Industries has a consensus target price of $43.10, suggesting a potential upside of 18.75%. Given Elanco Animal Health's higher probable upside, equities research analysts plainly believe Elanco Animal Health is more favorable than Teva Pharmaceutical Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
Teva Pharmaceutical Industries	0 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.91

Summary

Teva Pharmaceutical Industries beats Elanco Animal Health on 10 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to BeOne Medicines?

BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

In the previous week, BeOne Medicines had 5 more articles in the media than Elanco Animal Health. MarketBeat recorded 10 mentions for BeOne Medicines and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat BeOne Medicines' score of 1.22 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BeOne Medicines	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elanco Animal Health	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BeOne Medicines has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market.

BeOne Medicines has a net margin of 10.70% compared to Elanco Animal Health's net margin of -3.96%. BeOne Medicines' return on equity of 14.23% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BeOne Medicines	10.70%	14.23%	7.82%
Elanco Animal Health	-3.96%	8.13%	3.99%

BeOne Medicines currently has a consensus target price of $402.71, indicating a potential upside of 17.68%. Elanco Animal Health has a consensus target price of $29.09, indicating a potential upside of 25.53%. Given Elanco Animal Health's higher probable upside, analysts plainly believe Elanco Animal Health is more favorable than BeOne Medicines.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BeOne Medicines	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	3 Strong Buy rating(s)	3.00
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77

48.6% of BeOne Medicines shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 6.2% of BeOne Medicines shares are held by company insiders. Comparatively, 1.1% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

BeOne Medicines has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than BeOne Medicines, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BeOne Medicines	$5.34B	7.03	$286.93M	$5.68	60.25
Elanco Animal Health	$4.72B	2.46	-$232M	-$0.41	N/A

Summary

BeOne Medicines beats Elanco Animal Health on 13 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Royalty Pharma?

Elanco Animal Health (NYSE:ELAN) and Royalty Pharma (NASDAQ:RPRX) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Royalty Pharma has a net margin of 32.14% compared to Elanco Animal Health's net margin of -3.96%. Royalty Pharma's return on equity of 30.01% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-3.96%	8.13%	3.99%
Royalty Pharma	32.14%	30.01%	14.91%

Elanco Animal Health presently has a consensus target price of $29.09, suggesting a potential upside of 25.53%. Royalty Pharma has a consensus target price of $61.29, suggesting a potential upside of 3.09%. Given Elanco Animal Health's higher probable upside, equities analysts plainly believe Elanco Animal Health is more favorable than Royalty Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
Royalty Pharma	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 54.4% of Royalty Pharma shares are owned by institutional investors. 1.1% of Elanco Animal Health shares are owned by company insiders. Comparatively, 18.8% of Royalty Pharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Elanco Animal Health has a beta of 1.68, suggesting that its share price is 68% more volatile than the broader market. Comparatively, Royalty Pharma has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market.

Royalty Pharma has lower revenue, but higher earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Royalty Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.46	-$232M	-$0.41	N/A
Royalty Pharma	$2.38B	14.37	$770.95M	$1.45	41.00

In the previous week, Royalty Pharma had 7 more articles in the media than Elanco Animal Health. MarketBeat recorded 12 mentions for Royalty Pharma and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat Royalty Pharma's score of 0.66 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Royalty Pharma	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Royalty Pharma beats Elanco Animal Health on 10 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Zoetis?

Elanco Animal Health (NYSE:ELAN) and Zoetis (NYSE:ZTS) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

In the previous week, Zoetis had 13 more articles in the media than Elanco Animal Health. MarketBeat recorded 18 mentions for Zoetis and 5 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.30 beat Zoetis' score of 1.30 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zoetis	14 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 92.8% of Zoetis shares are owned by institutional investors. 1.1% of Elanco Animal Health shares are owned by company insiders. Comparatively, 0.2% of Zoetis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Elanco Animal Health currently has a consensus target price of $29.09, indicating a potential upside of 25.53%. Zoetis has a consensus target price of $101.08, indicating a potential upside of 38.13%. Given Zoetis' higher possible upside, analysts clearly believe Zoetis is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77
Zoetis	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32

Zoetis has a net margin of 27.49% compared to Elanco Animal Health's net margin of -3.96%. Zoetis' return on equity of 74.89% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	-3.96%	8.13%	3.99%
Zoetis	27.49%	74.89%	18.59%

Elanco Animal Health has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market. Comparatively, Zoetis has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Zoetis has higher revenue and earnings than Elanco Animal Health. Elanco Animal Health is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.72B	2.46	-$232M	-$0.41	N/A
Zoetis	$9.47B	3.19	$2.67B	$6.07	12.06

Summary

Zoetis beats Elanco Animal Health on 10 of the 17 factors compared between the two stocks.

How does Elanco Animal Health compare to Viatris?

Viatris (NASDAQ:VTRS) and Elanco Animal Health (NYSE:ELAN) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Elanco Animal Health has lower revenue, but higher earnings than Viatris. Elanco Animal Health is trading at a lower price-to-earnings ratio than Viatris, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viatris	$14.30B	1.30	-$3.51B	-$0.36	N/A
Elanco Animal Health	$4.72B	2.46	-$232M	-$0.41	N/A

Viatris has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, Elanco Animal Health has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market.

79.9% of Viatris shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 0.3% of Viatris shares are owned by company insiders. Comparatively, 1.1% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Viatris presently has a consensus target price of $18.57, indicating a potential upside of 14.32%. Elanco Animal Health has a consensus target price of $29.09, indicating a potential upside of 25.53%. Given Elanco Animal Health's stronger consensus rating and higher possible upside, analysts plainly believe Elanco Animal Health is more favorable than Viatris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viatris	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Elanco Animal Health	1 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.77

In the previous week, Elanco Animal Health had 2 more articles in the media than Viatris. MarketBeat recorded 5 mentions for Elanco Animal Health and 3 mentions for Viatris. Elanco Animal Health's average media sentiment score of 1.30 beat Viatris' score of 0.33 indicating that Elanco Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viatris	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Elanco Animal Health	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Viatris has a net margin of -2.79% compared to Elanco Animal Health's net margin of -3.96%. Viatris' return on equity of 20.02% beat Elanco Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viatris	-2.79%	20.02%	8.02%
Elanco Animal Health	-3.96%	8.13%	3.99%

Summary

Elanco Animal Health beats Viatris on 11 of the 17 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELAN vs. The Competition

Export

Metric	Elanco Animal Health	Pharmaceuticals Industry	Healthcare Sector	NYSE Exchange
Market Cap	$11.58B	$12.35B	$7.13B	$23.21B
Dividend Yield	N/A	2.61%	2.55%	3.76%
P/E Ratio	-56.55	797.25	273.68	28.56
Price / Sales	2.46	954.33	673.52	19.73
Price / Cash	10.33	91.31	77.55	34.36
Price / Book	1.76	10.47	10.48	4.72
Net Income	-$232M	$2.82B	$3.49B	$1.07B
7 Day Performance	-5.06%	-2.72%	-2.58%	-2.06%
1 Month Performance	4.11%	2.29%	0.51%	-2.59%
1 Year Performance	26.31%	4.62%	20.87%	10.89%

Elanco Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELAN Elanco Animal Health	4.7271 of 5 stars	$23.18 -1.6%	$29.09 +25.5%	+25.3%	$11.58B	$4.72B	N/A	9,900	Positive News
TEVA Teva Pharmaceutical Industries	4.2333 of 5 stars	$36.03 -1.1%	$42.22 +17.2%	+87.3%	$42.46B	$17.26B	60.05	33,950	Analyst Downgrade
ONC BeOne Medicines	4.2933 of 5 stars	$359.58 -1.9%	$402.14 +11.8%	0.0%	$40.26B	$5.34B	63.31	12,000	Positive News Analyst Forecast Gap Down
RPRX Royalty Pharma	3.7131 of 5 stars	$61.41 +0.9%	$60.86 -0.9%	+66.0%	$34.99B	$2.38B	42.35	80	Analyst Forecast
ZTS Zoetis	4.9101 of 5 stars	$76.99 -0.5%	$107.43 +39.5%	-51.0%	$31.96B	$9.47B	12.68	14,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ELAN) was last updated on 9/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Elanco Animal Health (ELAN) Competitors

ELAN vs. TEVA, ONC, RPRX, ZTS, and VTRS

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Summary

How does Elanco Animal Health compare to Royalty Pharma?

Summary

How does Elanco Animal Health compare to Zoetis?

Summary

How does Elanco Animal Health compare to Viatris?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Elanco Animal Health (ELAN) Competitors

ELAN vs. TEVA, ONC, RPRX, ZTS, and VTRS

How does Elanco Animal Health compare to Teva Pharmaceutical Industries?

Which has more volatility and risk, ELAN or TEVA?

Which has better earnings and valuation, ELAN or TEVA?

Does the media favor ELAN or TEVA?

Is ELAN or TEVA more profitable?

Do insiders & institutionals hold more shares of ELAN or TEVA?

Do analysts prefer ELAN or TEVA?

Summary

How does Elanco Animal Health compare to BeOne Medicines?

Does the media favor ONC or ELAN?

Which has more volatility and risk, ONC or ELAN?

Is ONC or ELAN more profitable?

Do analysts rate ONC or ELAN?

Do insiders and institutionals believe in ONC or ELAN?

Which has higher valuation and earnings, ONC or ELAN?

Summary

How does Elanco Animal Health compare to Royalty Pharma?

Is ELAN or RPRX more profitable?

Do analysts prefer ELAN or RPRX?

Do institutionals and insiders have more ownership in ELAN or RPRX?

Which has more risk & volatility, ELAN or RPRX?

Which has better earnings & valuation, ELAN or RPRX?

Does the media refer more to ELAN or RPRX?

Summary

How does Elanco Animal Health compare to Zoetis?

Does the media refer more to ELAN or ZTS?

Do institutionals and insiders believe in ELAN or ZTS?

Do analysts recommend ELAN or ZTS?

Is ELAN or ZTS more profitable?

Which has more volatility & risk, ELAN or ZTS?

Which has higher earnings & valuation, ELAN or ZTS?

Summary

How does Elanco Animal Health compare to Viatris?

Which has stronger valuation & earnings, VTRS or ELAN?

Which has more volatility & risk, VTRS or ELAN?

Do institutionals & insiders believe in VTRS or ELAN?

Do analysts rate VTRS or ELAN?

Does the media prefer VTRS or ELAN?

Is VTRS or ELAN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELAN vs. The Competition

Elanco Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools